Exclusive

Publication

Byline

Location

Is the colour of money changing the healthcare landscape

New Delhi, Aug. 24 -- Small nursing homes, trust-run hospitals and large corporate chains - India is dotted with these institutions delivering healthcare services, some for many years now. A recently... Read More


Sun Pharma's recall of eyedrops: Experts raise concerns on implementation and enforcement

New Delhi, Aug. 23 -- The recent voluntary withdrawal of Sun Pharmaceutical's eye drops has raised concerns on the implementation and enforcement of recalled products - as some retailers and regulator... Read More


QR coding for medicines needs to take the next leap in standardization of codes: GS1 CEO

New Delhi, Aug. 16 -- A QR code gives consumers information on a product, but that in isolation is not enough, says S Swaminathan, Chief Executive Officer with supply-chain standards organisation GS1 ... Read More


Of hospitality and hospitals: Health panel report calls for transparent pricing, grievance redressal mechanisms

New Delhi, Aug. 13 -- Complaints of opaque tariffs and hidden costs in private hospital bills, are often heard from patient families. But a recent Parliamentary panel report has flagged similar concer... Read More


'AI is not theoretical, or futuristic, it is already having an impact': Philips India MD

New Delhi, Aug. 11 -- Over 80 per cent of multinational company Philips' innovations in artificial intelligence, designed for global needs, is done in India, says Bharath Sesha, Managing Director, Phi... Read More


Sun Pharma voluntarily recalls 11 eyedrops from domestic market, experts seek details

New Delhi, Aug. 3 -- Drugmaker Sun Pharmaceutical Industries has undertaken a voluntary recall of some of its ophthalmic products in the domestic market, with reports suggesting that 11 eyedrops were ... Read More


PE firm ChrysCapital acquires Swiss parent's stake in Novartis India

New Delhi, July 30 -- Private equity firm ChrysCapital has acquired a controlling 70.68 per cent stake in Novartis India Limited (NIL), previously held by the parent company, Swiss drugmaker Novartis ... Read More


RPGLS growth plans includes semaglutide launch and plant acquisition

New Delhi, July 29 -- In a challenging environment, RPG Life Sciences has had discussions with 13 of its international customers to help absorb escalating input costs, and that has reflected in its fi... Read More


A plant-source Vitamin D3 looks to light-up Fermenta Biotech's prospects

New Delhi, July 28 -- Vitamin D3 is required at all stages of life, "from the cradle to the grave," says Fermenta Biotech Managing Director Prashant Nagre, on the prospects that open-up for their plan... Read More


RG Kar violence and after: Unfinished task of keeping hospitals safe

New Delhi, July 27 -- A recent video showing a political representative in an altercation with medical staff, including seemingly raising his hand on a female doctor, at a hospital in Dombivli, near M... Read More